Credit Suisse has build in USD 100 million in sales for Keveyis in FY17. “Taro launched Keveyis at a high price of USD 163.8 per tablet of 50mg. This implies annual cost of USD 120,000 per patient.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
